Trials / Completed
CompletedNCT02322294
Investigating the Effects of Glucodia™ on Glucose Parameters, Triglycerides and Body Weight
A Double-Blind, Placebo-Controlled, Parallel Study to Investigate the Effects of 8 Weeks Use of Glucodia™ on Glucose Parameters, Triglycerides and Body Weight as Compared to Placebo
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- KGK Science Inc. · Industry
- Sex
- All
- Age
- 21 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study is investigating the effects of 8 weeks of supplementation with Glucodia™, on glucose parameters, triglycerides and body weight as compared to a placebo. Half of the subjects will be administered Glucodia™, while the other half will receive placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Glucodia™ | |
| OTHER | Placebo |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2016-03-01
- First posted
- 2014-12-23
- Last updated
- 2016-06-09
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02322294. Inclusion in this directory is not an endorsement.